Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
JURA Bio, Inc. logo — Building the future of AI drug development with the data tha...

JURA Bio, Inc.

Building the future of AI drug development with the data that matters.

Founded 2017 United States Somerville, United States 13 employees Seed Total: $16.10M Biotechnology, Health Care +2

General Information

Company Name JURA Bio, Inc.
Founded Year 2017
Location United States Somerville, United States
Employees 13
Industries Biotechnology, Health Care, Health and Wellness +1
Funding Stage Seed
Business Model B2B, Platform, SaaS
Revenue Model Licensing, Service Fee, Subscription
Social

BounceWatch is an independent company data service, not affiliated with JURA Bio, Inc.. To contact JURA Bio, Inc., visit jurabio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does JURA Bio, Inc. compare?

A PDF of JURA Bio, Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting JURA Bio, Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About JURA Bio, Inc.

JURA Bio, Inc. is at the forefront of revolutionizing the potential of cell-based therapies. Founded in 2017, this United States-based company is carving out a niche in the Biotechnology and Life Sciences sectors with its innovative approach to gene editing.

The company’s slogan, "Building the future of cell-based therapies," encapsulates its mission to extend the capabilities of CAR-T technology beyond oncology, creating therapies that are not merely disease modifying, but curative and definitive. By developing a comprehensive therapeutic platform, JURA Bio aims to redefine the benchmarks in Health Care and Health and Wellness.

In its most recent financial milestone, JURA Bio secured a Seed Round investment of $16.10M on 21 September 2023. This funding round was led by notable investors including Fontus Capital, Michael Chambers, John Ballantyne, and Josh Ellington, reflecting significant investor confidence in the company's growth potential and strategic direction.

Business keywords: cell-based therapies, gene editing, therapeutic platform, CAR-T, oncology, disease modifying, curative, definitive, health innovation

Services & Products

AI model development for therapeutic design
Candidate drug discovery and development
Proprietary data generation and utilization
Partnerships for rapid biologics development

Target Customers

Biotechnology companies Pharmaceutical companies Research institutions focused on drug development Healthcare organizations involved in immune-based therapeutics

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Seed $16.10M 1
Fontus Capital
Fontus Capital
01 Sep 2023
Spinout Undisclosed 1
Harvard University
01 Jan 2017

JURA Bio, Inc. Alternatives & Competitors

View All Alternatives
JURA Bio, Inc. vs
Ixaka
Ixaka United Kingdom

An integrated cell and gene therapy company focused on the natural power of the body to cure disease

Venture round
11 employees
Biotechnology, Health Care
JURA Bio, Inc. vs
Neurona Therapeutics
Neurona Therapeutics United States

Building the next generation of cell-based medicines

Acquired
116 employees
Biotechnology, Health Care
JURA Bio, Inc. vs
Mekonos Inc.
Mekonos Inc. United States

Building the future of cell therapies on a chip.

6 employees
Biotechnology, Life Sciences
View all alternatives

FAQ About JURA Bio, Inc.

Building the future of AI drug development with the data that matters.
JURA Bio, Inc. was founded in 2017.
JURA Bio, Inc. is headquartered in Somerville, United States.
JURA Bio, Inc. operates in Biotechnology, Health Care, Health and Wellness and Life Sciences. Its work centres on cell-based therapies, gene editing, therapeutic platform and CAR-T. Its customers include Biotechnology companies, Pharmaceutical companies and Research institutions focused on drug development.
JURA Bio, Inc. has a B2B, Platform and SaaS business model. Its revenue comes from Licensing, Service Fee and Subscription.
JURA Bio, Inc. has approximately 13 employees.
JURA Bio, Inc. has completed 2 funding rounds, raising a total of $16.10M. The latest funding stage is Seed.
JURA Bio, Inc. offers: AI model development for therapeutic design, Candidate drug discovery and development, Proprietary data generation and utilization, Partnerships for rapid biologics development.
Top alternatives and competitors to JURA Bio, Inc. include Ixaka, Neurona Therapeutics, Mekonos Inc., HuidaGene Therapeutics, CellFE. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
JURA Bio, Inc. and Ixaka are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for JURA Bio, Inc., https://bouncewatch.com/company/jura-bio-inc, updated 19 July 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes